Exopolysaccharide biosynthesis locus (eps locus)

The **exopolysaccharide biosynthesis locus (eps locus)** is a gene cluster found in many bacteria that encodes proteins responsible for the assembly, polymerization, and export of exopolysaccharides (EPS), which are high-molecular-weight sugar polymers secreted outside the cell. The proteins encoded at this locus typically include glycosyltransferases, flippases (e.g., Wzx), polymerases (e.g., Wzy), transport/export proteins (OPX, ABC transporters), and sometimes regulatory proteins[1][2][3][4][5]. EPS production is a key determinant for biofilm formation, cell surface architecture, cell aggregation, and—particularly in pathogens—virulence and resistance to immune responses or environmental stresses[5][7]. The architecture and sequence of the eps locus can vary between species, and the structure of the polysaccharides produced (composition, branching, substituents) is determined by the specific complement of biosynthetic enzymes encoded within each locus[1][2][3][4][6]. Inactivation of these genes leads to loss of EPS synthesis and can compromise biofilm formation, motility, and development in various bacteria[1][2][3]. This locus is **not a single molecular therapeutic target** but may represent a potential avenue for anti-biofilm or anti-virulence drug strategies[5][7].

Other names

eps locusExopolysaccharide synthesis locusPolysaccharide biosynthesis gene cluster

Not applicable: There are no specific drugs with a defined mechanism of action against this gene locus. Potential mechanisms for agents that could interfere would be: - Inhibition of glycosyltransferase activity - Inhibition of flippase/polymerase/export proteins involved in EPS biosynthesis[1][2][3][5] - Some research compounds may target enzymes encoded within the locus, but no approved drugs.